oxycodone and HIV Coinfection

oxycodone has been researched along with HIV Coinfection in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (20.00)	18.2507
2000's	1 (10.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	5 (50.00)	2.80

Authors

Authors	Studies
de Guglielmo, G; Fu, Y; Giorgi, FM; Kim, HR; Lefebvre, C; Lorrai, I; Marquez Gaytan, J; Mercatelli, D; Repunte-Canonigo, V; Sanna, PP; Shankula, C; Sumazin, P; Zorman, B	1
Athota, P; Guda, C; Jagadesan, S; Nguyen, NM; Pendyala, G; Schaal, VL; Yelamanchili, SV	1
Beheshti, D	1
Box, JG; Foster, M; Jackson, D; Mahdi, F; Paris, JJ; Qrareya, AN; Salahuddin, MF; Vujanovic, T	1
Mahdi, F; Paris, JJ; Salahuddin, MF	1
Mahdi, F; Paris, JJ; Salahuddin, MF; Sulochana, SP	1
Hagelberg, NM; Laine, K; Neuvonen, M; Neuvonen, PJ; Nieminen, TH; Olkkola, KT; Saari, TI	1
Stanberry, L; Volpi, A	1
Anand, A; Carmosino, L; Glatt, AE	1

Trials

1 trial(s) available for oxycodone and HIV Coinfection

Article	Year
Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir. European journal of clinical pharmacology, 2010, Volume: 66, Issue:10 Topics: Adult; Analgesics, Opioid; Area Under Curve; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Finland; HIV Infections; HIV Protease Inhibitors; Humans; Linear Models; Lopinavir; Male; Oxycodone; Pain; Pyrimidinones; Reference Values; Ritonavir; Time Factors; Young Adult	2010

Article

Year

Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir.

European journal of clinical pharmacology, 2010, Volume: 66, Issue:10

Topics: Adult; Analgesics, Opioid; Area Under Curve; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Finland; HIV Infections; HIV Protease Inhibitors; Humans; Linear Models; Lopinavir; Male; Oxycodone; Pain; Pyrimidinones; Reference Values; Ritonavir; Time Factors; Young Adult

2010

Other Studies

9 other study(ies) available for oxycodone and HIV Coinfection

Article	Year
Escalated (Dependent) Oxycodone Self-Administration Is Associated with Cognitive Impairment and Transcriptional Evidence of Neurodegeneration in Human Immunodeficiency Virus (HIV) Transgenic Rats. Viruses, 2022, 03-24, Volume: 14, Issue:4 Topics: Analgesics, Opioid; Animals; Cognitive Dysfunction; Glucocorticoids; HIV; HIV Infections; Humans; Oxycodone; Rats; Rats, Transgenic	2022
Novel RNA-Seq Signatures Post-Methamphetamine and Oxycodone Use in a Model of HIV-Associated Neurocognitive Disorders. Viruses, 2023, 09-19, Volume: 15, Issue:9 Topics: Animals; HIV Infections; HIV-1; Humans; Methamphetamine; Neurocognitive Disorders; Oxycodone; RNA-Seq	2023
Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of OxyContin. Health economics, 2019, Volume: 28, Issue:12 Topics: Analgesics, Opioid; Drug Administration Routes; Drug Overdose; Hepatitis A; Hepatitis B; Hepatitis C; Heroin; HIV Infections; Humans; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Substance Abuse, Intravenous; Technology, Pharmaceutical; United States	2019
Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice. Hormones and behavior, 2020, Volume: 119 Topics: Animals; Anxiety; Cognitive Dysfunction; Drug Combinations; Female; Gonadal Steroid Hormones; Gonads; HIV Infections; HIV-1; Humans; Hypothalamo-Hypophyseal System; Mice; Mice, Transgenic; Mood Disorders; Neurotoxicity Syndromes; Oxycodone; Pituitary-Adrenal System; Psychomotor Disorders; tat Gene Products, Human Immunodeficiency Virus; Tumor Cells, Cultured	2020
HIV-1 Tat Dysregulates the Hypothalamic-Pituitary-Adrenal Stress Axis and Potentiates Oxycodone-Mediated Psychomotor and Anxiety-Like Behavior of Male Mice. International journal of molecular sciences, 2020, Nov-03, Volume: 21, Issue:21 Topics: Animals; Anxiety Disorders; Depression; Disease Progression; Drug Interactions; HIV Infections; HIV-1; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Transgenic; Mood Disorders; Oxycodone; Pituitary-Adrenal System; Psychomotor Disorders; Stress, Psychological; tat Gene Products, Human Immunodeficiency Virus	2020
HIV-1 Tat Protein Promotes Neuroendocrine Dysfunction Concurrent with the Potentiation of Oxycodone's Psychomotor Effects in Female Mice. Viruses, 2021, 04-30, Volume: 13, Issue:5 Topics: Animals; Behavior, Animal; Disease Models, Animal; Estrous Cycle; Female; HIV Infections; HIV-1; Humans; Hypothalamo-Hypophyseal System; Mice; Motor Activity; Neurosecretory Systems; Oxycodone; Pituitary-Adrenal System; Pregnanolone; Psychomotor Performance; Steroids; tat Gene Products, Human Immunodeficiency Virus	2021
Herpes zoster in immunocompromised patients. Herpes : the journal of the IHMF, 2007, Volume: 14, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Analgesics, Opioid; Antiviral Agents; Hematologic Neoplasms; Herpes Zoster; HIV Infections; Humans; Immunocompromised Host; Incidence; Middle Aged; Oxycodone	2007
Evaluation of recalcitrant pain in HIV-infected hospitalized patients. Journal of acquired immune deficiency syndromes, 1994, Volume: 7, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Adult; Chronic Disease; Female; Fentanyl; HIV Infections; Hospitalization; Humans; Infant; Male; Morphine; Oxycodone; Pain; Substance Abuse, Intravenous	1994
Denial of specific medicine is not 'deliberate indifference'. AIDS policy & law, 1996, Feb-09, Volume: 11, Issue:2 Topics: Analgesics, Opioid; HIV Infections; Humans; Oxycodone; Pain; Pennsylvania; Prisoners; Refusal to Treat; Treatment Refusal	1996